Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.
about
Collagen structure and stabilitySelectivity in glycosaminoglycan binding dictates the distribution and diffusion of fibroblast growth factors in the pericellular matrix.Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cellsFell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra.Novel method for expression and purification of human pigment epithelium-derived factor with biological activities in Escherichia coli.Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cellsConsortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen.Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices.The extracellular matrix and blood vessel formation: not just a scaffold.In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growthSynthesis and biological applications of collagen-model triple-helical peptides.Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.Isolation, characterization and biological evaluation of jellyfish collagen for use in biomedical applications.Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains.Induction of endothelial cell activation by a triple helical alpha2beta integrin ligand, derived from type I collagen alpha1(I)496-507.Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity.Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1).Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression.The collαgen III fibril has a "flexi-rod" structure of flexible sequences interspersed with rigid bioactive domains including two with hemostatic roles.Mutation in the heparan sulfate biosynthesis enzyme EXT1 influences growth factor signaling and fibroblast interactions with the extracellular matrix.Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans.Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesionInteraction of the collagen-like tail of asymmetric acetylcholinesterase with heparin depends on triple-helical conformation, sequence and stability.Direct-write assembly of 3D silk/hydroxyapatite scaffolds for bone co-cultures.Pmarg-pearlin is a matrix protein involved in nacre framework formation in the pearl oyster Pinctada margaritifera.Ovarian carcinoma cells synthesize both chondroitin sulfate and heparan sulfate cell surface proteoglycans that mediate cell adhesion to interstitial matrix.Growth inhibition of prostate cancer xenografts by halofuginone.Revealing Accessibility of Cryptic Protein Binding Sites within the Functional Collagen Fibril.Crafting of functional biomaterials by directed molecular self-assembly of triple helical peptide building blocks.A polyelectrolyte multilayer platform for investigating growth factor delivery modes in human liver cultures.Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering.Extracellular matrix-inspired assembly of glycosaminoglycan–collagen fibers
P2860
Q24610632-F52AB9C1-190F-4761-89C2-CD69F3594C02Q27336444-C8717ED4-4438-4764-9EEC-A7224E47CFF2Q28144354-0EBFB1F4-8599-4AFB-BBA4-DA1689AB4850Q30568524-A5092CFA-8264-46CD-BB52-3012E2C4FC1DQ33235324-5E5C35C4-8CDE-45B3-A0A6-46DECFD2B33EQ33426878-E768672C-C507-4092-9665-4B57799DD7E8Q34088135-0EF3F9A6-60D1-4B6A-8D72-A6E03B1CE444Q34101398-8AD27276-518D-4668-A55E-9E1184AFB5ECQ34786160-C7B5CACC-5588-4316-BA98-4171993D09F5Q35073707-CC763F16-64E6-46A6-B63D-6936C55B544FQ36815331-24AC5155-41C1-48FB-860B-0CEE5DA97C4EQ37233876-85240984-2F8E-4166-9D09-68F8042114D9Q37632930-71216FFD-0D4B-4280-B1E8-2D7F1EDD7A36Q39078431-D6ACF8B0-D4C6-4EF0-9EDB-DB7789F7AF88Q39508574-9F3AA0B0-D54C-47DE-9D02-27B368FCC373Q39627497-0FB35C44-DDE4-4B45-AF3F-DDAA36E5A7C3Q40622330-453E70E4-7944-487A-B821-B84EDBC731B3Q40703354-24D841E0-BD9D-41E1-877E-A9866298FA19Q40781744-8EFE34B4-40CC-4E4A-B08A-F66C060DE2D7Q40821781-4366860B-151B-4EEE-BC77-03EA75B85D31Q41006430-07EBCBD3-4646-4F7C-858E-01AA6A0F9082Q41808585-DCDB2D9A-17CC-4A67-A34E-0B89F16F7E07Q41851531-568A9795-38F6-4FED-B80B-74F82265FF31Q41896828-F6815A32-94AB-4AC1-8FBF-0BBCD25F965DQ41993170-78B0EFB1-1D73-473F-B0D4-31C0F1D2D217Q42011503-BCA55F95-9413-4D3A-B279-3E6B44D87C1CQ43662413-637A6A42-13BB-409A-9363-1C324AA8113BQ43748131-749ECEF4-3CD9-4A0D-9C1D-20B0A8726411Q43956506-A18FF930-A005-4BC4-B924-F9DE87E993A3Q47112384-81FFAD65-CF3B-4BE2-A3D1-8697F809D637Q47339467-29881482-F02F-4D51-B130-EA3D456B76CBQ47346458-A6E4904B-B801-4C7B-8033-E568FAF0F9A7Q47434720-E2217577-EB8B-4464-9C09-AD7DF3443C57Q57170648-41C35D34-0B9E-4C8F-AA53-7DB4C2E5C7EE
P2860
Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Defining the domains of type I ...... nd endothelial tube formation.
@ast
Defining the domains of type I ...... nd endothelial tube formation.
@en
type
label
Defining the domains of type I ...... nd endothelial tube formation.
@ast
Defining the domains of type I ...... nd endothelial tube formation.
@en
prefLabel
Defining the domains of type I ...... nd endothelial tube formation.
@ast
Defining the domains of type I ...... nd endothelial tube formation.
@en
P2093
P2860
P356
P1476
Defining the domains of type I ...... nd endothelial tube formation.
@en
P2093
G B Fields
J D San Antonio
S M Sweeney
P2860
P304
P356
10.1073/PNAS.95.13.7275
P407
P577
1998-06-01T00:00:00Z